Stand UP to Rheumatoid Arthritis (SUPRA)

计划入组 75 人 · 首次发布于 2022 年 3 月 31 日

TNFi Plus Low-Dose Upadacitinib vs TNFi Intensification in Crohn's Disease With Suboptimal Response

计划入组 312 人 · 首次发布于 2026 年 4 月 3 日

To Estimate the Efficacy of Treatment With TNFi as Monotherapy or Combination Therapy With MTX and Compare and Contrast Efficacy With Tofacitinib as Monotherapy and Combination Therapy in a Real World Setting.

计划入组 9,159 人 · 首次发布于 2022 年 10 月 12 日

TNF2

AnxA5MOD-TNFa

Lock-TNFα

TNF Pharmaceuticals, Inc.

United States

Ignite Biomedical's AI-Driven TNFi Treatment Response Predictor Achieves Analytical Validation

FDA Approves Bimekizumab (Bimzelx) for Psoriatic Arthritis and Axial Spondyloarthritis

Bimekizumab Shows Sustained Efficacy in Psoriatic Arthritis at 2 Years